cohort study with rheumatoid arthritis: a nationwide risk of cardiovascular disease in patients Non-steroidal anti-inflammatory drugs and

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study

  2012cited by this paper
• Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

  2011cited by this paper
• Validation of rheumatoid arthritis diagnoses in health care utilization data

  2011cited by this paper
• Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

  2011cited by this paper
• Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study

  2011cited by this paper
• Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity

  2010cited by this paper
• Risk of Myocardial Infarction and Death Associated With the Use of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs) Among Healthy Individuals: A Nationwide Cohort Study

  2009cited by this paper
• Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.

  2009cited by this paper
• Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

  2008cited by this paper
• Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients

  2008cited by this paper
• Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.

  2008cited by this paper
• The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

  2008cited by this paper
• Role of inflammation in atherosclerosis associated with rheumatoid arthritis.

  2008cited by this paper
• Validity of Stroke Diagnoses in a National Register of Patients

  2007cited by this paper
• Trend in mortality after stroke with atrial fibrillation.

  2007cited by this paper
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

  2006cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

  2006cited by this paper
• Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.

  2005cited by this paper
• Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis

  2004cited by this paper
• Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis.

  2004cited by this paper
• The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry.

  2003cited by this paper
• Predicting mortality in patients with rheumatoid arthritis.

  2003cited by this paper
• Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.

  2002cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• The Danish National Hospital Register. A valuable source of data for modern health sciences.

  1999cited by this paper
• Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

  1999cited by this paper
• The Danish prescription registries.

  1997cited by this paper

• Autism Spectrum Disorders: An Intervention Approach Based on Genomic Analysis

  2014cites this paper